PLATELET-RICH PLASMA THERAPY FOR ERECTILE DYSFUNCTION: A REVIEW OF PRECLINICAL AND CLINICAL STUDIES

Erectile dysfunction is no longer a psychosocial problem. Nowadays, it is a marker specific for the initial stages of cardiovascular diseases. Рlatelet-rich plasma (PRP) is a new and promising method, which totally deserves to be noted by specialists. To review currently existing pre-clinical and cl...

Full description

Bibliographic Details
Main Authors: A. D. Kaprin, A. A. Kostin, M. V. Epifanova, M. E. Chalyy, E. V. Gameeva, S. A. Artemenko
Format: Article
Language:Russian
Published: QUASAR, LLC 2019-09-01
Series:Issledovaniâ i Praktika v Medicine
Subjects:
Online Access:https://www.rpmj.ru/rpmj/article/view/423
_version_ 1797874051566272512
author A. D. Kaprin
A. A. Kostin
M. V. Epifanova
M. E. Chalyy
E. V. Gameeva
S. A. Artemenko
author_facet A. D. Kaprin
A. A. Kostin
M. V. Epifanova
M. E. Chalyy
E. V. Gameeva
S. A. Artemenko
author_sort A. D. Kaprin
collection DOAJ
description Erectile dysfunction is no longer a psychosocial problem. Nowadays, it is a marker specific for the initial stages of cardiovascular diseases. Рlatelet-rich plasma (PRP) is a new and promising method, which totally deserves to be noted by specialists. To review currently existing pre-clinical and clinical studies concerning application of PRP in erectile dysfunction published in international sources such as PubMed, Cochrane Library, Clinicaltrials.gov. The current data of preclinical and clinical studies determine the absence of PRP side effects and the effectiveness for ED treatment. PRP-therapy is a pathogenetically substantiated method of treating erectile dysfunction. The therapy is designed for repair and regeneration of endothelium, smooth muscle cells, and connective tissue. However, large, placebo-controlled, multicenter studies are needed to creation a systematic review and meta-analysis.
first_indexed 2024-04-10T01:25:50Z
format Article
id doaj.art-3de98a87df5a4d18bbf17fe8b54a06f3
institution Directory Open Access Journal
issn 2410-1893
language Russian
last_indexed 2024-04-10T01:25:50Z
publishDate 2019-09-01
publisher QUASAR, LLC
record_format Article
series Issledovaniâ i Praktika v Medicine
spelling doaj.art-3de98a87df5a4d18bbf17fe8b54a06f32023-03-13T09:35:00ZrusQUASAR, LLCIssledovaniâ i Praktika v Medicine2410-18932019-09-0163748610.17709/2409-2231-2019-6-3-7276PLATELET-RICH PLASMA THERAPY FOR ERECTILE DYSFUNCTION: A REVIEW OF PRECLINICAL AND CLINICAL STUDIESA. D. Kaprin0A. A. Kostin1M. V. Epifanova2M. E. Chalyy3E. V. Gameeva4S. A. Artemenko5ФГБУ «Национальный медицинский исследовательский центр радиологии» Министерства здравоохранения Российской Федерации; Медицинский институт ФГАОУ ВО «Российский университет дружбы народов»ФГБУ «Национальный медицинский исследовательский центр радиологии» Министерства здравоохранения Российской Федерации; ФГАОУ ВО «Российский университет дружбы народов»Медицинский институт ФГАОУ ВО «Российский университет дружбы народов; ФГАОУ ВО «Российский университет дружбы народов»Медицинский научно-образовательный центр ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»Московский научно-исследовательский онкологический институт им. П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Министерства здравоохранения Российской ФедерацииФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский университет)Erectile dysfunction is no longer a psychosocial problem. Nowadays, it is a marker specific for the initial stages of cardiovascular diseases. Рlatelet-rich plasma (PRP) is a new and promising method, which totally deserves to be noted by specialists. To review currently existing pre-clinical and clinical studies concerning application of PRP in erectile dysfunction published in international sources such as PubMed, Cochrane Library, Clinicaltrials.gov. The current data of preclinical and clinical studies determine the absence of PRP side effects and the effectiveness for ED treatment. PRP-therapy is a pathogenetically substantiated method of treating erectile dysfunction. The therapy is designed for repair and regeneration of endothelium, smooth muscle cells, and connective tissue. However, large, placebo-controlled, multicenter studies are needed to creation a systematic review and meta-analysis.https://www.rpmj.ru/rpmj/article/view/423аутоплазмаобогащенная тромбоцитарными факторами роста (аот)эректильная дисфункция (эд)сексуальная дисфункцияэректильная функция (эф)факторы ростаклеточная терапия
spellingShingle A. D. Kaprin
A. A. Kostin
M. V. Epifanova
M. E. Chalyy
E. V. Gameeva
S. A. Artemenko
PLATELET-RICH PLASMA THERAPY FOR ERECTILE DYSFUNCTION: A REVIEW OF PRECLINICAL AND CLINICAL STUDIES
Issledovaniâ i Praktika v Medicine
аутоплазма
обогащенная тромбоцитарными факторами роста (аот)
эректильная дисфункция (эд)
сексуальная дисфункция
эректильная функция (эф)
факторы роста
клеточная терапия
title PLATELET-RICH PLASMA THERAPY FOR ERECTILE DYSFUNCTION: A REVIEW OF PRECLINICAL AND CLINICAL STUDIES
title_full PLATELET-RICH PLASMA THERAPY FOR ERECTILE DYSFUNCTION: A REVIEW OF PRECLINICAL AND CLINICAL STUDIES
title_fullStr PLATELET-RICH PLASMA THERAPY FOR ERECTILE DYSFUNCTION: A REVIEW OF PRECLINICAL AND CLINICAL STUDIES
title_full_unstemmed PLATELET-RICH PLASMA THERAPY FOR ERECTILE DYSFUNCTION: A REVIEW OF PRECLINICAL AND CLINICAL STUDIES
title_short PLATELET-RICH PLASMA THERAPY FOR ERECTILE DYSFUNCTION: A REVIEW OF PRECLINICAL AND CLINICAL STUDIES
title_sort platelet rich plasma therapy for erectile dysfunction a review of preclinical and clinical studies
topic аутоплазма
обогащенная тромбоцитарными факторами роста (аот)
эректильная дисфункция (эд)
сексуальная дисфункция
эректильная функция (эф)
факторы роста
клеточная терапия
url https://www.rpmj.ru/rpmj/article/view/423
work_keys_str_mv AT adkaprin plateletrichplasmatherapyforerectiledysfunctionareviewofpreclinicalandclinicalstudies
AT aakostin plateletrichplasmatherapyforerectiledysfunctionareviewofpreclinicalandclinicalstudies
AT mvepifanova plateletrichplasmatherapyforerectiledysfunctionareviewofpreclinicalandclinicalstudies
AT mechalyy plateletrichplasmatherapyforerectiledysfunctionareviewofpreclinicalandclinicalstudies
AT evgameeva plateletrichplasmatherapyforerectiledysfunctionareviewofpreclinicalandclinicalstudies
AT saartemenko plateletrichplasmatherapyforerectiledysfunctionareviewofpreclinicalandclinicalstudies